Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2026-01-01 @ 3:00 PM
Study NCT ID:
NCT06745492
Status:
COMPLETED
Last Update Posted:
2024-12-20
First Post:
2024-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery
Sponsor:
Seoul National University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-25
Completion Date Type:
ACTUAL
First Submit Date:
2024-12-17
First Submit QC Date:
None
Study First Post Date:
2024-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-17
Last Update Post Date:
2024-12-20
Last Update Post Date Type:
ACTUAL